| Bioactivity | AGL 2043 is an effective inhibitor of PDGFR and TEL-PDGFR kinases, capable of effectively inhibiting the proliferation of pig heart smooth muscle cells and balloon-induced vascular stenosis. AGL 2043 is suitable for development as an anti-restenosis and anti-cancer agent[1]. |
| CAS | 226717-28-8 |
| Formula | C15H12N4S |
| Molar Mass | 280.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gazit A, et al. Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit. Bioorg Med Chem. 2003;11(9):2007-2018. |